Incidencia de hepatitis b en pacientes con HIV en el Hospital General Monte Sinaí durante el periodo 2022 - 2024.

Abstract

Introduction: HIV and HBV are infections that can coexist and accelerate disease progression and complicate treatment. The mode of transmission of these infections is similar, occurring mainly through sexual transmission and IV drug use. Aim: To determine the incidence of hepatitis B in patients with HIV at HGMS during the period 2022 – 2024. Method: the methodology implemented was descriptive, correlational, cross-sectional,, and retrospective. Results: The incidence of HBV in patients with HIV was 19.3 cases / 100 patients. Coinfection predominated in men (61,1%) with 30 – 39 years (30,6%). Most patients were in the AIDS phase in 88,9% with CD4 levels below 50 cells (72,2%). The main risk factors associated with coinfection were being homosexual, not being vaccinated against hepatitis b, having multiple sexual partners, not using condom, and IV drug (p = 0,000). Conclusions: The presence og HIV and HBV as coinfection is common, especially in patients with advanced HIV; furthermore, IV drug use and risky sexual practices significantly increase the risk of acquiring both infections.